InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: None

Wednesday, 07/18/2018 4:12:44 PM

Wednesday, July 18, 2018 4:12:44 PM

Post# of 18220
Here is another link to a most interesting 4 year old publication in the journal Expert Review of Anticancer Therapy. The link is to the National Library of Medicine (NLM) Pubmed site. It is an abstract of the article, however on the upper right on that page you will see View Full Text. Click that and it will take you to the publisher's site. There a link is found for .pdf copy of the article. Click that and the five page article will download free of charge.

Dr. Ian Zagon is an advisor to IMUN/Cytocom and the article is about very important therapeutic potentials for methionine enkephalin (MENK) for which, as you should know, IMUN possesses use patents. OGF (Opioid Growth Factor) is methionine enkephalin.

This article is food for thought and provides just more indication of lost opportunity for IMUN/Cytocom in progressing with the needed clinical studies for which the companies were established. Note on page 249 of article under Financial & Competing Interests Disclosure. Reminder-TNI Biotech Inc. is now IMUN.

Here is the link: www.ncbi.nlm.nih.gov/pubmed/24397732